Coronavirus vaccine shots given worldwide
- Thread starter ghazi52
- Start date
ghazi52
PDF THINK TANK: ANALYST
- Joined
- Mar 21, 2007
- Messages
- 102,010
- Reaction score
- 106
- Country
- Location
PARIS: More than five billion anti-Covid jabs have been given globally, an AFP tally of official sources at 1430 GMT on Tuesday showed, with the worldwide inoculation drive reaching cruising speed.
While it took around 140 days to get the first billion shots into people's arms, the third, fourth and fifth billions each took between 26 and 30 days, the data show.
Nearly 40 percent (1.96 billion) of the five billion shots have been administered in China. India (589 million) and the United States (363 million) make up the trio of countries that have given the most jabs.
In terms of population protected among countries with more than one million people, the United Arab Emirates is the leader. It has administered 179 doses per 100 inhabitants, meaning it has fully vaccinated nearly 75 percent of its population.
Uruguay follows with 154 per 100 inhabitants, Israel (149), Qatar (148), Singapore (147), Bahrain (144), Denmark (143), Chile (140), Canada (139), Portugal and Belgium (138 each), China (136), Spain (134), Ireland (133) and the United Kingdom (132).
Most of these countries have fully vaccinated between 65 percent and 70 percent of their populations.
Some, like the Emirates, Bahrain, Israel, Uruguay and Chile have even started giving out booster shots to prolong the immunity of the fully vaccinated.
France, which will start giving booster shots from mid-September, is not far behind, with 126 doses injected per 100 people and 62 percent of the population completely vaccinated.
It has bypassed the United States which has given 110 doses per 100 inhabitants, with 52 percent completely vaccinated.
Most poor countries have now started to vaccinate, mainly thanks to the Covax scheme, but the coverage remains very unequal.
High-income countries (as defined by the World Bank) administered an average of 111 doses per 100 inhabitants compared with just 2.4 doses in low-income countries.
Injections in these countries have picked up recently after donations by some richer countries.
On average around the world 64 doses have been injected per 100 inhabitants.
Three countries have yet to start their vaccination drives: Burundi, Eritrea and North Korea.
While it took around 140 days to get the first billion shots into people's arms, the third, fourth and fifth billions each took between 26 and 30 days, the data show.
Nearly 40 percent (1.96 billion) of the five billion shots have been administered in China. India (589 million) and the United States (363 million) make up the trio of countries that have given the most jabs.
In terms of population protected among countries with more than one million people, the United Arab Emirates is the leader. It has administered 179 doses per 100 inhabitants, meaning it has fully vaccinated nearly 75 percent of its population.
Uruguay follows with 154 per 100 inhabitants, Israel (149), Qatar (148), Singapore (147), Bahrain (144), Denmark (143), Chile (140), Canada (139), Portugal and Belgium (138 each), China (136), Spain (134), Ireland (133) and the United Kingdom (132).
Most of these countries have fully vaccinated between 65 percent and 70 percent of their populations.
Some, like the Emirates, Bahrain, Israel, Uruguay and Chile have even started giving out booster shots to prolong the immunity of the fully vaccinated.
France, which will start giving booster shots from mid-September, is not far behind, with 126 doses injected per 100 people and 62 percent of the population completely vaccinated.
It has bypassed the United States which has given 110 doses per 100 inhabitants, with 52 percent completely vaccinated.
Most poor countries have now started to vaccinate, mainly thanks to the Covax scheme, but the coverage remains very unequal.
High-income countries (as defined by the World Bank) administered an average of 111 doses per 100 inhabitants compared with just 2.4 doses in low-income countries.
Injections in these countries have picked up recently after donations by some richer countries.
On average around the world 64 doses have been injected per 100 inhabitants.
Three countries have yet to start their vaccination drives: Burundi, Eritrea and North Korea.
Pfizer CEO chooses not to be vaccinated.
www.bitchute.com
Pfizer CEO "Im 59, I'm healthy. My health type is to recommend not to get vaccinated"
BitChute is a video service that prioritizes creators and champions users' freedoms and privacy.
www.bitchute.com
ghazi52
PDF THINK TANK: ANALYST
- Joined
- Mar 21, 2007
- Messages
- 102,010
- Reaction score
- 106
- Country
- Location
32.9% of the world population has received at least one dose of a COVID-19 vaccine, and 24.8% is fully vaccinated.
5.04 billion doses have been administered globally, and 33.69 million are now administered each day.
Only 1.4% of people in low-income countries have received at least one dose.
5.04 billion doses have been administered globally, and 33.69 million are now administered each day.
Only 1.4% of people in low-income countries have received at least one dose.
ghazi52
PDF THINK TANK: ANALYST
- Joined
- Mar 21, 2007
- Messages
- 102,010
- Reaction score
- 106
- Country
- Location
FDA NEWS RELEASE
FDA Approves First COVID-19 Vaccine
Approval Signifies Key Achievement for Public Health
August 23, 2021
Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.
“The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic. While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product,” said Acting FDA Commissioner Janet Woodcock, M.D. “While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.”
Since Dec. 11, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been available under EUA in individuals 16 years of age and older, and the authorization was expanded to include those 12 through 15 years of age on May 10, 2021. EUAs can be used by the FDA during public health emergencies to provide access to medical products that may be effective in preventing, diagnosing, or treating a disease, provided that the FDA determines that the known and potential benefits of a product, when used to prevent, diagnose, or treat the disease, outweigh the known and potential risks of the product.
FDA Approves First COVID-19 Vaccine
Approval Signifies Key Achievement for Public Health
August 23, 2021
Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.
“The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic. While this and other vaccines have met the FDA’s rigorous, scientific standards for emergency use authorization, as the first FDA-approved COVID-19 vaccine, the public can be very confident that this vaccine meets the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product,” said Acting FDA Commissioner Janet Woodcock, M.D. “While millions of people have already safely received COVID-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated. Today’s milestone puts us one step closer to altering the course of this pandemic in the U.S.”
Since Dec. 11, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been available under EUA in individuals 16 years of age and older, and the authorization was expanded to include those 12 through 15 years of age on May 10, 2021. EUAs can be used by the FDA during public health emergencies to provide access to medical products that may be effective in preventing, diagnosing, or treating a disease, provided that the FDA determines that the known and potential benefits of a product, when used to prevent, diagnose, or treat the disease, outweigh the known and potential risks of the product.
ghazi52
PDF THINK TANK: ANALYST
- Joined
- Mar 21, 2007
- Messages
- 102,010
- Reaction score
- 106
- Country
- Location
After six months: Protection against Covid waning among vaccinated people, says study
News Report
Thursday, Aug 26, 2021
By News report
LONDON: Protection against the coronavirus is waning among those who have received both shots of the AstraZeneca and Pfizer vaccines, a new UK study has found, foreign media reported.
An analysis from the UK's ZOE Covid app study of over 400,000 people who had received both shots of the Pfizer-BioNTech vaccine, showed that it was 88% effective in protecting against the coronavirus a month after receiving both shots.However, its effectiveness fell to 74% five or six months after receiving both doses of the Pfizer vaccine.
In the same study, an analysis of over 700,000 people who had received both doses of the Oxford-AstraZeneca vaccine showed its effectiveness fell from 77% after a month to 67% at the four to five month mark.
The data was collected after May 26, when the delta variant became the dominant strain, said Tim Spector, who is running the ongoing ZOE Covid app study.
News Report
Thursday, Aug 26, 2021
By News report
LONDON: Protection against the coronavirus is waning among those who have received both shots of the AstraZeneca and Pfizer vaccines, a new UK study has found, foreign media reported.
An analysis from the UK's ZOE Covid app study of over 400,000 people who had received both shots of the Pfizer-BioNTech vaccine, showed that it was 88% effective in protecting against the coronavirus a month after receiving both shots.However, its effectiveness fell to 74% five or six months after receiving both doses of the Pfizer vaccine.
In the same study, an analysis of over 700,000 people who had received both doses of the Oxford-AstraZeneca vaccine showed its effectiveness fell from 77% after a month to 67% at the four to five month mark.
The data was collected after May 26, when the delta variant became the dominant strain, said Tim Spector, who is running the ongoing ZOE Covid app study.
ghazi52
PDF THINK TANK: ANALYST
- Joined
- Mar 21, 2007
- Messages
- 102,010
- Reaction score
- 106
- Country
- Location
The biggest vaccination campaign in history is underway. More than 5.11 billion doses have been administered across 183 countries, according to data collected by Bloomberg.
The latest rate was roughly 38.4 million doses a day.
In the U.S., 366 million doses have been given so far. In the last week, an average of 877,756 doses per day were administered.
The latest rate was roughly 38.4 million doses a day.
In the U.S., 366 million doses have been given so far. In the last week, an average of 877,756 doses per day were administered.
ghazi52
PDF THINK TANK: ANALYST
- Joined
- Mar 21, 2007
- Messages
- 102,010
- Reaction score
- 106
- Country
- Location
The biggest vaccination campaign in history is underway. More than 5.17 billion doses have been administered across 183 countries, according to data collected by Bloomberg. The latest rate was roughly 39.6 million doses a day.
In the U.S., 367 million doses have been given so far. In the last week, an average of 886,314 doses per day were administered.
In the U.S., 367 million doses have been given so far. In the last week, an average of 886,314 doses per day were administered.
ghazi52
PDF THINK TANK: ANALYST
- Joined
- Mar 21, 2007
- Messages
- 102,010
- Reaction score
- 106
- Country
- Location
The biggest vaccination campaign in history is underway.
More than 5.26 billion doses have been administered across 183 countries, according to data collected by Bloomberg. The latest rate was roughly 41 million doses a day.
In the U.S., 370 million doses have been given so far. In the last week, an average of 898,446 doses per day were administered.
More than 5.26 billion doses have been administered across 183 countries, according to data collected by Bloomberg. The latest rate was roughly 41 million doses a day.
In the U.S., 370 million doses have been given so far. In the last week, an average of 898,446 doses per day were administered.
ghazi52
PDF THINK TANK: ANALYST
- Joined
- Mar 21, 2007
- Messages
- 102,010
- Reaction score
- 106
- Country
- Location
More than 5.29 billion doses have been administered across 183 countries,
The biggest vaccination campaign in history is underway. More than 5.29 billion doses have been administered across 183 countries, according to data collected by Bloomberg. The latest rate was roughly 41 million doses a day.
More than 5.29 billion vaccine doses have been administered worldwide, equal to 69 doses for every 100 people.
In the U.S., 370 million doses have been given so far. In the last week, an average of 898,446 doses per day were administered.
The biggest vaccination campaign in history is underway. More than 5.29 billion doses have been administered across 183 countries, according to data collected by Bloomberg. The latest rate was roughly 41 million doses a day.
More than 5.29 billion vaccine doses have been administered worldwide, equal to 69 doses for every 100 people.
In the U.S., 370 million doses have been given so far. In the last week, an average of 898,446 doses per day were administered.
ghazi52
PDF THINK TANK: ANALYST
- Joined
- Mar 21, 2007
- Messages
- 102,010
- Reaction score
- 106
- Country
- Location
PARIS: The novel coronavirus has killed at least 4,507,823 people since the outbreak emerged in China in December 2019, according to a tally from official sources compiled by AFP at 1000 GMT on Tuesday.
At least 216,980,860 cases of coronavirus have been registered.
The vast majority have recovered, though some have continued to experience symptoms weeks or even months later.
The figures are based on daily reports provided by health authorities in each country.
They exclude revisions made by other statistical organisations, which show that the number of deaths is much higher.
The World Health Organization estimates that the pandemic's overall toll could be two to three times higher than official records, due to the excess mortality that is directly and indirectly linked to Covid-19.
A large number of the less severe or asymptomatic cases also remain undetected, despite intensified testing in many countries.
On Monday, 8,361 new deaths and 663,689 new cases were recorded worldwide.
Based on latest reports, the countries with the most new deaths were United States with 1,135 new deaths, followed by Russia with 795 and Iran with 669.
The United States is the worst-affected country with 638,715 deaths from 39,057,665 cases.
After the US, the hardest-hit countries are Brazil with 579,574 deaths from 20,752,281 cases, India with 438,560 deaths from 32,768,880 cases, Mexico with 258,491 deaths from 3,341,264 cases, and Peru with 198,263 deaths from 2,149,591 cases.
The country with the highest number of deaths compared to its population is Peru with 601 fatalities per 100,000 inhabitants, followed by Hungary with 311, Bosnia-Herzegovina with 298, Czech Republic with 284, Republic of North Macedonia with 283 and Montenegro with 274.
Latin America and the Caribbean overall has 1,437,488 deaths from 43,203,496 cases, Europe 1,248,655 deaths from 63,032,296 infections, and Asia 777,746 deaths from 50,092,953 cases.
The United States And Canada has reported 665,616 deaths from 40,548,811 cases, Africa 195,477 deaths from 7,769,229 cases, Middle East 181,132 deaths from 12,214,235 cases, and Oceania 1,709 deaths from 119,844 cases.
As a result of corrections by national authorities or late publication of data, the figures updated over the past 24 hours may not correspond exactly to the previous day's tallies.
At least 216,980,860 cases of coronavirus have been registered.
The vast majority have recovered, though some have continued to experience symptoms weeks or even months later.
The figures are based on daily reports provided by health authorities in each country.
They exclude revisions made by other statistical organisations, which show that the number of deaths is much higher.
The World Health Organization estimates that the pandemic's overall toll could be two to three times higher than official records, due to the excess mortality that is directly and indirectly linked to Covid-19.
A large number of the less severe or asymptomatic cases also remain undetected, despite intensified testing in many countries.
On Monday, 8,361 new deaths and 663,689 new cases were recorded worldwide.
Based on latest reports, the countries with the most new deaths were United States with 1,135 new deaths, followed by Russia with 795 and Iran with 669.
The United States is the worst-affected country with 638,715 deaths from 39,057,665 cases.
After the US, the hardest-hit countries are Brazil with 579,574 deaths from 20,752,281 cases, India with 438,560 deaths from 32,768,880 cases, Mexico with 258,491 deaths from 3,341,264 cases, and Peru with 198,263 deaths from 2,149,591 cases.
The country with the highest number of deaths compared to its population is Peru with 601 fatalities per 100,000 inhabitants, followed by Hungary with 311, Bosnia-Herzegovina with 298, Czech Republic with 284, Republic of North Macedonia with 283 and Montenegro with 274.
Latin America and the Caribbean overall has 1,437,488 deaths from 43,203,496 cases, Europe 1,248,655 deaths from 63,032,296 infections, and Asia 777,746 deaths from 50,092,953 cases.
The United States And Canada has reported 665,616 deaths from 40,548,811 cases, Africa 195,477 deaths from 7,769,229 cases, Middle East 181,132 deaths from 12,214,235 cases, and Oceania 1,709 deaths from 119,844 cases.
As a result of corrections by national authorities or late publication of data, the figures updated over the past 24 hours may not correspond exactly to the previous day's tallies.
ghazi52
PDF THINK TANK: ANALYST
- Joined
- Mar 21, 2007
- Messages
- 102,010
- Reaction score
- 106
- Country
- Location
More than 5.33 billion vaccine doses have been administered worldwide, equal to 69 doses for every 100 people. There is already a stark gap between vaccination programs in different countries,.
ghazi52
PDF THINK TANK: ANALYST
- Joined
- Mar 21, 2007
- Messages
- 102,010
- Reaction score
- 106
- Country
- Location
The biggest vaccination campaign in history is underway. More than 5.39 billion doses have been administered across 183 countries, according to data collected by Bloomberg. The latest rate was roughly 41 million doses a day.
In the U.S., 372 million doses have been given so far. In the last week, an average of 910,432 doses per day were administered.
Enough doses have now been administered to fully vaccinate 35.1% of the global population—but the distribution has been lopsided. Countries and regions with the highest incomes are getting vaccinated more than 20 times faster than those with the lowest.
When will life return to normal?
While the best vaccines are highly effective at preventing hospitalization and death, it takes a coordinated campaign to stop a pandemic. Infectious-disease experts say that vaccinating 70% to 85% of the U.S. population would enable a return to normalcy.
On a global scale, that’s a daunting level of vaccination. At the current pace of 41 million a day, the goal of high levels of global immunity remains a long way off. Manufacturing capacity, however, is steadily increasing, and new vaccines by additional manufacturers are coming to market.
The Path to Immunity Around the World
Globally, the latest vaccination rate is 40,990,666 doses per day, on average. At this pace, it will take another 5 months to cover 75% of the population.
In the U.S., 372 million doses have been given so far. In the last week, an average of 910,432 doses per day were administered.
Enough doses have now been administered to fully vaccinate 35.1% of the global population—but the distribution has been lopsided. Countries and regions with the highest incomes are getting vaccinated more than 20 times faster than those with the lowest.
When will life return to normal?
While the best vaccines are highly effective at preventing hospitalization and death, it takes a coordinated campaign to stop a pandemic. Infectious-disease experts say that vaccinating 70% to 85% of the U.S. population would enable a return to normalcy.
On a global scale, that’s a daunting level of vaccination. At the current pace of 41 million a day, the goal of high levels of global immunity remains a long way off. Manufacturing capacity, however, is steadily increasing, and new vaccines by additional manufacturers are coming to market.
The Path to Immunity Around the World
Globally, the latest vaccination rate is 40,990,666 doses per day, on average. At this pace, it will take another 5 months to cover 75% of the population.
ghazi52
PDF THINK TANK: ANALYST
- Joined
- Mar 21, 2007
- Messages
- 102,010
- Reaction score
- 106
- Country
- Location
Vaccines halve long-term COVID-19 effects: Study
https://nation.com.pk/NewsSource/anadolu
Anadolu
12:18 PM | September 03, 2021
A double dose of a vaccine is most likely to halve the likelihood of long-term COVID-19 effects for adults, according to a study released on Thursday.
Research conducted by a team from King’s College London showed that double-jabbed people who contract the virus were 73% less likely to be admitted to a hospital, while severe symptoms were reduced by almost a third.
“We found that the odds of having symptoms for 28 days or more after post-vaccination infection were approximately halved by having two vaccine doses,” read the study published in a scientific journal.
“This result suggests that the risk of long COVID is reduced in individuals who have received double vaccination, when additionally considering the already documented reduced risk of infection overall.”
The team analyzed data from more than 2 million people who logged their symptoms, tests, and vaccination status on the UK’s COVID Symptom Study app from last December to this July.
A total of 6,030 of them tested positive for the virus within at least two weeks of their first dose, while only 2,370 users tested positive at least a week after receiving their second jab.
People who were fully vaccinated reported milder and less frequent symptoms of the virus than those who were not inoculated, the study said.
Additionally, double-jabbed adults aged over 60 were more likely to have no symptoms when compared to those not vaccinated, showing the efficacy of the jabs in protecting the elderly and most vulnerable.
https://nation.com.pk/NewsSource/anadolu
Anadolu
12:18 PM | September 03, 2021
A double dose of a vaccine is most likely to halve the likelihood of long-term COVID-19 effects for adults, according to a study released on Thursday.
Research conducted by a team from King’s College London showed that double-jabbed people who contract the virus were 73% less likely to be admitted to a hospital, while severe symptoms were reduced by almost a third.
“We found that the odds of having symptoms for 28 days or more after post-vaccination infection were approximately halved by having two vaccine doses,” read the study published in a scientific journal.
“This result suggests that the risk of long COVID is reduced in individuals who have received double vaccination, when additionally considering the already documented reduced risk of infection overall.”
The team analyzed data from more than 2 million people who logged their symptoms, tests, and vaccination status on the UK’s COVID Symptom Study app from last December to this July.
A total of 6,030 of them tested positive for the virus within at least two weeks of their first dose, while only 2,370 users tested positive at least a week after receiving their second jab.
People who were fully vaccinated reported milder and less frequent symptoms of the virus than those who were not inoculated, the study said.
Additionally, double-jabbed adults aged over 60 were more likely to have no symptoms when compared to those not vaccinated, showing the efficacy of the jabs in protecting the elderly and most vulnerable.
Similar threads
